Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +2.79% | -24.37% | +183.76% |
Jun. 04 | Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer | CI |
May. 21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 18-08-02 |
Director of Finance/CFO | 49 | 23-08-31 | |
Sergei Gryaznov
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 20-03-31 | |
Ramiro Guerrero
BRD | Director/Board Member | 59 | - |
Steven Chaouki
BRD | Director/Board Member | 51 | 21-09-27 |
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 18-08-02 |
Cristian Luput
BRD | Director/Board Member | 49 | 19-04-30 |
Stan Smith
BRD | Director/Board Member | 77 | - |
Director/Board Member | 57 | 23-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,837,149 | 17,936,419 ( 82.14 %) | 0 | 82.14 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.76% | 72.5M | |
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- MAIA Stock
- Company MAIA Biotechnology, Inc.